Institute of Bioorganic Chemistry

http://iboch.bas-net.by/  

Technology for the creation and production of a number of hemosorbents

COUNTRY OF ORIGIN

IDENTIFIER

BO3908

PUBLISHED

2021-05-21

LAST UPDATE

2021-05-21

DEADLINE

Linked profile in other language
Responsible
Aleksej Yantsevich
+375 17 357 8761
info@iboch.by
Summary
The Institute of Bioorganic Chemistry offers consumers a number of hemosorbents under a manufactoring agreement and is looking for partners to sell the technology for creating a number of hemosorbents and conclude an agreement on distribution services.
Description
Hemosorbents (Hemo-Proteazsorb, LPS-Hemo, Anti-IgE-Hemo) are medical products that are designed to remove harmful substances of various nature from the blood for certain diseases (oncological, autoimmune, infectious, allergic, etc.).
Advantages and Innovations
Pilot batches have been developed, trademark certificates have been obtained, production facilities have been certified, products are registered in the Republic of Belarus and Ukraine.
Stage of development
Already on the market
Comments regarding stage of development
A production site was created and 4,726 hemosorbents "Gemo-Proteazsorb" were produced,
"LPS-Hemo", "Anti-IgE-Hemo".
Funding source
State budged
Internal
IPR status
Exclusive rights
Secret know-how
Trade marks
Sector group
BioChemTech
Healthcare

Organization information

Type
R&D institution
Year established
1974
NACE keywords
A.01.61 - Support activities for crop production
M.72.19 - Other research and experimental development on natural sciences and engineering
M.74.90 - Other professional, scientific and technical activities n.e.c.
Q.86.90 - Other human health activities
Turnover (in EUR)
10-20M
Already engaged in transnational cooperation
Yes
Additional comments
A significant amount of fundamental research is carried out under the grants of the Belarusian Republican Foundation for Basic Research, including with the participation of international partners - organizations from Russia, the Czech Republic, etc.
Languages spoken
English
Russian

Information about partnership

Type of partnership considered
Distribution services agreement
Manufacturing agreement
Type and role of partner sought
Consumers of a number of hemosorbents under a manufacturing agreement.
Partners for the sale of technology for creating a number of hemosorbents and the conclusion of an agreement on distribution services.
Type and size of partner sought
> 500
251-500
SME 51-250
SME 11-50
SME <= 10
R&D Institution

Attachments

Views: 1616
Statistics since 22.05.2021 14:15:00